AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Biology & Medicine Article
PDF (286.9 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Letter | Open Access

A retrospective analysis of mature T- and NK-cell lymphomas

Junlei Jia1,*, Xiaohui Wang1,*, Zheng Song1,*, Shen Meng1,2,*, Yue Fei1, Jingwei Yu1, Xia Liu1, Xue Han1, Lanfang Li1, Lihua Qiu1, Zhengzi Qian1, Shiyong Zhou1( ), Wenchen Gong3, Bin Meng3, Xiubao Ren4, Xianhuo Wang1 ( ), Huilai Zhang1 ( )
National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, and Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin 300060, China
Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
Department of Pathology; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin 300060, China
Department of Immunology/Biotherapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin 300060, China

*These authors contributed equally to this work.

Show Author Information

Electronic Supplementary Material

Download File(s)
cbm-21-3-223_ESM.pdf (1.1 MB)

References

1

Shah N, Herrera DA, Shah U, Kolla BC, Kaur G, Sica RA, et al. Unique racial patterns in rare T-cell lymphomas: a national cancer registry analysis from 2001 to 2015. J Clin Oncol. 2019; 37.
Crossref Google Scholar
2
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Incidence-SEER Research Data, 17 Registries, based on the November 2022 submission (2000-2020) - linked to county attributes - time dependent (1990-2021) income/rurality, 1969-2021 counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission.
3

Yoon SE, Song Y, Kim SJ, Yoon DH, Chen TY, Koh Y, et al. Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia. Lancet Reg Health West Pac. 2021; 10: 100126.
Crossref Google Scholar
4

Yamaguchi M, Kita K, Miwa H, Nishii K, Oka K, Ohno T, et al. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer. 1995; 76: 2351-6.
Crossref Google Scholar
5

Shi Y, Dong M, Hong X, Zhang W, Feng J, Zhu J, et al. Results from a multicenter, open-label, pivotal phase Ⅱ study of chidamide in relapsed or refractory peripheral T-cell lymphoma. Ann Oncol. 2015; 26: 1766-71.
Crossref Google Scholar
6

Maomao C, He L, Dianqin S, Siyi H, Xinxin Y, Fan Y, et al. Current cancer burden in China: epidemiology, etiology, and prevention. Cancer Biol Med. 2022; 19: 1121-38.
Crossref Google Scholar
7

Sun J, Yang Q, Lu Z, He M, Gao L, Zhu M, et al. Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol. 2012; 138: 429-34.
Crossref Google Scholar
8

Li YY, Feng LL, Niu SQ, Wang HY, Zhang LL, Wang L, et al. Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy. Oncotarget. 2017; 8: 11480-8.
Crossref Google Scholar
9

Zhang W, Su L, Liu L, Gao Y, Wang Q, Su H, et al. The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study. Cancer Biol Med. 2021; 18: 841-8.
Crossref Google Scholar
10

Sandell RF, Boddicker RL, Feldman AL. Genetic landscape and classification of peripheral T cell lymphomas. Curr Oncol Rep. 2017; 19: 28.
Crossref Google Scholar
11

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127: 2375-90.
Crossref Google Scholar
12

Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014; 32: 3059-68.
Crossref Google Scholar
13

Ansell SM, Habermann TM, Kurtin PJ, Witzig TE, Chen MG, Li CY, et al. Predictive capacity of the international prognostic factor index in patients with peripheral T-cell lymphoma. J Clin Oncol. 1997; 15: 2296-301.
Crossref Google Scholar
14

Kim SJ, Yoon DH, Jaccard A, Chng WJ, Lim ST, Hong H, et al. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016; 17: 389-400.
Crossref Google Scholar
15

Chen SY, Yang Y, Qi SN, Wang Y, Hu C, He X, et al. Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making. Leukemia. 2021; 35: 130-42.
Crossref Google Scholar
16

Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004; 103: 2474-9.
Crossref Google Scholar
17

Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol. 2006; 24: 2472-9.
Crossref Google Scholar
18

Gutierrez-Garcia G, Garcia-Herrera A, Cardesa T, Martinez A, Villamor N, Ghita G, et al. Comparison of four prognostic scores in peripheral t-cell lymphoma. Ann Oncol. 2011; 22: 397-404.
Crossref Google Scholar
Cancer Biology & Medicine
Volume 21 Issue 3,
March 2024
Pages 223-229
DOI: 10.20892/j.issn.2095-3941.2023.0464
Cite this article:
Jia J, Wang X, Song Z, et al. A retrospective analysis of mature T- and NK-cell lymphomas. Cancer Biology & Medicine, 2024, 21(3): 223-229. https://doi.org/10.20892/j.issn.2095-3941.2023.0464

111

Views

8

Downloads

0

Crossref

1

Web of Science

0

Scopus

Altmetrics
Received: 22 December 2023
Accepted: 08 February 2024
Published: 27 March 2024
©2024 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License
Return